Armando OrlandiΒ· @ArmandOrlandi Β· XΒ·Β· 2 days agoScore70
Body
Cowabunga! π Riding the Early & Adjuvant Breast Cancer Wave ππ»ββοΈπ€π» from #ESMO26
NATALEE, 6 yrs: ribociclib overall survival hazard ratio 0.81, +2.1%.
Encouraging, concordant, consistent. But: no alpha, nominal p, fragility ~2β3 deaths.
@OncoDaily #OncoDailyAmbassador
@OncoAlert
135 views Β· 0 likes Β· 0 reposts Β· 0 replies
Conference abstracts
LBA25matched by Proffered paper 1: Breast cancer, early and advanced stage
Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2β early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes
https://esmocongress.esmo.orgSource: Armando Orlandi Β· x.com